Since its inception in 1920, The Union has had a focus on tuberculosis (TB) and innovating TB care.
We have now set out our 2022-2027 vision, objectives and strategy for ending TB. This can only be achieved collectively, with our members, partners and TB community – everyone has a role to play.
Together, we can bring an end to TB.
Our work in TB
The Union works towards the global elimination of TB. We support high-quality, accessible prevention and care for people with and at risk of TB, to expand the evidence base for TB care and prevention and implement new knowledge into policy and practice.
Project Axshya
In collaboration with local partners and over 15,000 community volunteers, The Union provided innovative tuberculosis (TB) interventions designed to serve traditionally hard-to-reach and at-risk populations in India.
Specific TB priority areas
Read more about how The Union is working to fight key areas of TB:
Child & Adolescent Tuberculosis
The Union works to develop, test, implement and scale up routine screening of child contacts of people with TB. We run observational studies and advocate to ensure children and adolescents are included in clinical trials that target diagnostics, vaccines and treatment of TB disease and infection.
TB-HIV, TB-Diabetes and other co-morbidities
The Union develops, tests, implements and scales up models of care for co-morbid conditions that increase the risk of developing TB, that are prevalent in high TB burden settings, or that adversely affect TB treatment outcomes.
The Zoonotic TB Sub-section was instrumental in the creation of the first-ever Roadmap for Zoonotic TB, a policy document that addressed the major health and economic impacts of the disease, created in collaboration with the World Health Organization.
Members work together to influence global policy and practice, ensuring their work has a greater global impact.
Understand the issues with our factsheets
Tuberculosis Union news
Survivors of TB and other lung diseases are invited to attend the 51st Union World Conference on Lung Health free-of-charge
To hold governments accountable for global commitments and to find solutions to tuberculosis (TB) and lung disease, it is essential to…
Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria
Letter to the editors giving an early view into the impact of COVID-19 on TB diagnosis in Nigeria, a high burden setting for TB.
Union applauds the price reduction announced for bedaquiline for the treatment of drug-resistant TB in low- and middle-income countries
The Union welcomes the announcement made on Monday that bedaquiline will be made available to Stop TB Partnership’s Global Drug Facility…
The Global Plan to End TB 2018–2022 is now available to download in three languages
The ‘Global Plan to End TB 2018–2022: The Paradigm Shift’ is an updated costed plan and roadmap for a concerted response to tuberculosis…
How COVID-19 can instruct TB research: ensuring the safety of researchers exposed to infectious disease
A letter to the editors of the IJTLD which highlights the need to mitigate the risk of researchers being exposed to TB and other airborne pathogens.
Union article highlights how the SDG framework can act on determinants and risk factors of TB
The United Nations Sustainable Development Goals (SDGs) framework provides a means to act on the socio-economic determinants of…
TB Publications
Until recently, the focus has been on finding and treating people with TB. But now bold targets for TB prevention have been outlined in the recent UN High-Level Meeting on TB. The Union develops, tests, implements and scales up models of care to increase the uptake and completion of TB preventive treatments in key high risk groups including children under 5 and people living with HIV.
'Prevent Tuberculosis: Management of TB Infection' is a free course which improves knowledge of all aspects of the management of TB infection including the diagnosis and treatment of tuberculosis with the specific aim of increasing country-level implementation of TB prevention among i) household contact of people affected by TB, especially those under five years of age, ii) persons with risk factors to develop TB, and iii) people living with HIV in care.